IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#4203
Positioning
Market Dominance
Services
Computer Software
$14.0B
Eric Lefkofsky
We endeavor to unlock the true power of precision medicine by creating Intelligent Diagnostics through the practical application of artificial intelligence, or AI, in healthcare. Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. We were founded by Eric Lefkofsky, originally formed under the name Bioin LLC in Delaware in August 2015 and we converted to a Delaware corporation in September 2015 under the name Bioin Inc. We changed our name to Tempus Health, Inc. later in 2015, to Tempus Labs, Inc. in 2016 and in 2023, we changed our name to Tempus AI, Inc. Our principal executive offices are located at 600 West Chicago Avenue, Suite 510 Chicago, Illinois.
Headcount
—
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = TEM ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$YALA Yalla Group Ltd | 75 | 89 | 99 | 80 | - | - | 21.3% | 18.6% | 64.5% | 35.7% | 39.5% | 6.5% | 0.0% | 0.0x | $644M | VS | |
$GRVY GRAVITY Co., Ltd. | 75 | 82 | 96 | 71 | - | - | 15.4% | 12.6% | 38.7% | 17.1% | 17.0% | -39.7% | 0.0% | 0.0x | $439M | VS | |
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC | 73 | 81 | 88 | 94 | 25.0x | 14.1x | 28.1% | 16.8% | 48.1% | 23.8% | 18.5% | 78.6% | 0.0% | 37.0x | $220M | VS | |
$AER AerCap Holdings N.V. | 72 | 60 | 87 | 84 | - | - | 12.4% | 2.9% | 100.0% | 28.2% | 26.2% | 5.5% | 0.8% | 264.0x | $19.4B | VS | |
$HCSG HEALTHCARE SERVICES GROUP INC | 72 | 74 | 88 | 88 | 7.1x | 6.1x | 28.9% | 20.8% | 20.8% | 9.9% | 9.3% | 8.5% | 0.0% | 1.0x | $1.2B | VS | |
$LQDT LIQUIDITY SERVICES INC | 72 | 90 | 88 | 68 | 24.9x | 14.3x | 14.6% | 7.8% | 43.8% | 7.4% | 5.9% | 31.2% | 0.0% | 0.0x | $857M | VS | |
$TRTNpA Triton International Ltd | 71 | 70 | 89 | 70 | - | 1.7x | 18.0% | 4.6% | 97.3% | 52.2% | 32.7% | -3.4% | 0.0% | 271.0x | $8.0B | VS | |
$EDU New Oriental Education & Technology Group Inc. | 71 | 83 | 52 | 77 | - | - | 9.4% | 4.9% | 55.5% | 8.7% | 7.7% | 13.6% | 1.3% | 7.0x | $78.0B | VS | |
$NTES NetEase, Inc. | 71 | 88 | 93 | 68 | - | - | 22.1% | 15.6% | 62.5% | 28.1% | 28.7% | -1.0% | 2.8% | 9.0x | $56.6B | VS | |
$UTI UNIVERSAL TECHNICAL INSTITUTE INC | 70 | 86 | 86 | 72 | 43.2x | 16.0x | 21.4% | 8.0% | 100.0% | 10.0% | 7.5% | 14.1% | 0.0% | 27.0x | $1.8B | VS | |
$TEM Tempus AI, Inc. | 34 | 25 | 31 | 43 | - | - | -52.5% | -11.7% | 63.0% | -23.6% | -26.5% | 101.4% | 0.0% | 349.0x | $14.0B | ||
| SECTOR BENCH | - | - | - | - | - | 23.7x | 11.7x | 5.3% | 1.9% | 59.6% | 3.5% | 2.3% | 7.8% | 0.0% | 0.3x | - | REF |
Tempus AI, Inc. (TEM) receives a "Avoid" rating with a composite score of 34.1/100. It ranks #4203 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Eric Lefkofsky
Chief Executive Officer
25
18
33
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for TEM
HQ Base
CHICAGO, Illinois
In-line with peers — no strong momentum signal
Expensive relative to fundamentals — limited margin of safety
Weak fundamentals — higher risk of value trap
High volatility — wider range of outcomes increases timing risk
Aggressive spending — empire-building risk, dilutive growth
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Services sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for TEM.
View All RatingsMaterial decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 25 | 10 | +15ALPHA |
| MOMENTUM | 43 | 39 | +4NEUTRAL |
| VALUATION | 31 | 24 | +7ALPHA |
| INVESTMENT | 18 | 1 | +17ALPHA |
| STABILITY | 33 | 26 | +7ALPHA |
| SHORT INT | 43 | 38 | +5NEUTRAL |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC -8.2% vs WACC 8.9% (spread -17.1%)
GM 63% vs sector 60%, OM -24% vs sector 4%
Capital turnover 0.57x, R&D intensity 13.5%
Rev growth 101%, 2yr history
Interest coverage -2.2x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our quantitative model flags Tempus AI, Inc. with an Avoid rating, assigning a composite score of 34.1/100 and 1 out of 5 stars. Ranked #4203 of 7,333 stocks, TEM falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
TEM's quality score of 25/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of -52.5% (sector avg: 5.3%), gross margins of 63.0% (sector avg: 59.6%), net margins of -26.5% (sector avg: 2.3%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
With a value score of 31/100, TEM appears somewhat expensive relative to its fundamentals. Key valuation metrics include a P/B ratio of 20.45x. Investors paying a premium here are likely betting on above-average growth or margin expansion to justify current prices.
Tempus AI, Inc.'s investment score of 18/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 101.4% vs. a sector average of 7.8% and a return on assets of -11.7% (sector: 1.9%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
TEM is currently showing below-average momentum at 43/100, which may indicate weakening institutional interest or negative sentiment shifts. Revenue growth stands at 101.4% year-over-year, while a beta of 2.42 reflects its sensitivity to broader market moves. Investors should note that declining momentum can precede further price weakness, though contrarian opportunities sometimes emerge at these levels.
TEM's stability score of 33/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of 2.42 and a debt-to-equity ratio of 349.00x (sector avg: 0.3x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
The short interest score of 43/100 for TEM suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include high market sensitivity (beta: 2.42), elevated leverage (D/E: 349.00x). With a $14.0B market cap (large-cap), Tempus AI, Inc. may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
Tempus AI, Inc. is a large-cap company in the Services sector, ranked #0 of 50 in its sector (100th percentile) and #4203 of 7,333 overall (43rd percentile). Key comparisons include ROE of -52.5% trailing the 5.3% sector median and operating margins of -23.6% below the 3.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Services peers.
While TEM currently exhibits a AVOID profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Services Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Investment (18) would have the largest impact on the composite score.
ROE 1089% BELOW SECTOR MEDIAN
Gross Margin 6% ABOVE SECTOR MEDIAN (FAVORABLE)
Op. Margin 772% BELOW SECTOR MEDIAN
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate Tempus AI, Inc. (TEM) as Avoid with a composite score of 34.1/100 at a current price of $58.03. The stock falls in the bottom quintile of our universe across key quantitative factors, and the multi-factor weakness suggests a high probability of continued underperformance.
The rating is primarily driven by strength in momentum (43th percentile) and stability (33th percentile), which together account for the majority of the composite score. Offsetting weakness in investment (18th percentile) and quality (25th percentile) tempers our overall conviction. We assign a No Moat rating (33/100), Very High uncertainty, and Poor capital allocation.
Key items to watch: balance sheet deleveraging progress; sustainability of the current growth rate; the path to profitability. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
Tempus AI, Inc. holds a top-quartile position (#0 of 50) within the Services sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 34.1/100 places it at rank #4203 in our full 7,333-stock universe. With a $14.0B market capitalization, Tempus AI, Inc. operates at meaningful scale within the Services sector, providing competitive advantages in distribution, procurement, and customer reach.
Revenue is growing at 101%, though momentum at the 43th percentile suggests the market has not yet fully recognized this trajectory. This potential disconnect between fundamental improvement and market recognition could represent an opportunity for patient investors if the growth trend persists.
The margin cascade tells an important story: gross margins of 63% (+3.4pp vs sector) narrow to operating margins of -24% (-27.1pp vs sector) and net margins of -26.5%, yielding a gross-to-net conversion rate of -42%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $58.03, Tempus AI, Inc. is trading at a premium to fundamental value. Our value factor score of 31/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The premium valuation implies the market is pricing in significant future growth or quality improvements that are not yet fully reflected in current fundamentals.
The stock currently trades at P/B of 20.4x, P/S of 9.6x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
Gross margins of 63% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
Revenue growth of 101% confirms the business is expanding its addressable market — growth at this level typically supports multiple expansion and attracts institutional capital.
The Avoid rating (composite 34.1/100) reflects multi-factor weakness, and historically, stocks in this scoring range have underperformed the market by a meaningful margin.
Elevated leverage (349% D/E) amplifies downside risk and limits management's financial flexibility in adverse scenarios.
Thin net margins of -26.5% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
We assign a Very High uncertainty rating to Tempus AI, Inc.. The stock exhibits multiple compounding risk factors: elevated market sensitivity (beta of 2.42), significant leverage (349% debt-to-equity), current negative profitability (net margin -26.5%). The extreme uncertainty around future cash flows makes precise valuation difficult, and the range of outcomes is exceptionally wide. Only investors with high risk tolerance and extended time horizons should consider this name.
Specific risk factors that inform our assessment include: elevated market sensitivity (beta of 2.42); significant leverage (349% debt-to-equity); current negative profitability (net margin -26.5%); below-average price stability (33th percentile). Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 33th percentile and quality factor at the 25th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 63% provide a buffer against cost pressures. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile warrants caution and disciplined position management.
We rate Tempus AI, Inc.'s capital allocation as Poor. Key concerns include low returns on equity (-52.5%), elevated leverage (349% D/E), negative profitability, weak asset returns (ROA -11.7%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — Tempus AI, Inc. significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, Tempus AI, Inc. receives a Avoid rating with a composite score of 34.1/100 (rank #4203 of 7,333). Our quantitative framework assigns a No Moat (33/100, trend: stable), Very High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 30/100.
Our analysis does not support a constructive view on Tempus AI, Inc. at this time. The combination of limited competitive advantages, very high uncertainty, and poor capital allocation suggests unfavorable risk-reward at current levels. We recommend investors avoid new positions and existing holders consider reducing exposure.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign Tempus AI, Inc. a meaningful economic moat, scoring 33/100 on our composite assessment. The ROIC-WACC spread of -17.1% is the primary signal of economic value creation. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, growth durability, reached only 14.7/20.
The strongest moat sources are growth durability (14.7/20) and margin superiority (7.3/20). Rev growth 101%, 2yr history. GM 63% vs sector 60%, OM -24% vs sector 4%. These pillars form the core of Tempus AI, Inc.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include financial resilience (2.5/20) and economic value creation (3.3/20). Interest coverage -2.2x. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect Tempus AI, Inc.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 63% providing a solid profitability foundation, robust top-line growth of 101% expanding the revenue base. The margin cascade from 63% gross to -24% operating to -26.5% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality raises some durability concerns, with the quality factor at the 25th percentile.
The margin profile shows gross margins of 63%, operating margins of -24%, net margins of -26.5%. Return metrics include ROE of -52.5% and ROA of -11.7%. Relative to the Services sector, gross margins are 3.4 percentage points above the sector median of 60%, and ROE of -52.5% compares to a sector median of 5.3%.
The balance sheet reflects high leverage with D/E of 349%, which may limit financial flexibility, revenue growth of 101%. The sector median D/E is 0%, putting Tempus AI, Inc. at higher leverage than the typical peer. Elevated leverage in combination with the current margin profile warrants close monitoring for any deterioration in debt-servicing capacity.
Below-average quality (25th percentile) raises durability concerns about the fundamental profile and increases the risk of negative earnings surprises.
High beta of 2.42 means amplified losses in market selloffs — in a broad market correction, this stock would likely decline more than the index.
Tempus AI (NasdaqGS:TEM) announced new study results for its Immune Profile Score (IPS) test, which showed improved prediction of immunotherapy outcomes compared to conventional biomarkers. This could expand access to immune checkpoint inhibitor therapy and has attracted investor interest due to its potential in diagnostics, oncology, and AI-enabled clinical decision support. The company's IPS update aligns with its strategy to leverage rich oncology data and AI for growth, however, challenges include profitability, reimbursement, and competition from larger diagnostic players.

U.S. stock futures declined on Monday following tensions between the DOJ and Federal Reserve over Chair Powell's congressional testimony. Major indices fell 0.57-1.04% in premarket trading. Key movers included Vistra (up on Meta nuclear deal), Alibaba (up on AI milestone), Tempus AI (up on strong 2025 results), and XPeng (up on delivery growth). The market awaits key economic data this week including CPI and jobless claims.
Kahn Swick & Foti, LLC (KSF) is reminding investors of Tempus AI, Inc. (NasdaqGS: TEM) who suffered losses exceeding $100,000 of the lead plaintiff deadline on August 12, 2025, in a securities class action lawsuit. The lawsuit alleges that Tempus AI and its executives failed to disclose material information during the Class Period, specifically regarding overstated AI capabilities, aggressive accounting, and issues with management and past financial reporting. Investors who purchased shares between August 6, 2024, and May 27, 2025, are affected.

Nancy Pelosi and her husband Paul filed their first 2026 financial disclosures, revealing bullish stock moves in major tech companies including Nvidia, Alphabet, and Amazon through exercised call options. Their portfolio of five stocks achieved approximately 41.7% returns over one year, double the S&P 500 performance, demonstrating their successful long-term investing track record focused on AI and technology sectors.
Tempus AI launched its HRD-RNA algorithm, an AI-driven model for identifying Homologous Recombination Deficiency in cancer patients. The company also partnered with Median Technologies to integrate the eyonis LCS AI tool for lung cancer screening in the US and Europe. These updates expand Tempus AI's diagnostic offerings in both treatment selection and early lung cancer detection. Tempus AI, trading on NasdaqGS:TEM, is drawing attention with these product and partnership moves at a share...
Above 50MA
37.18%
Net New Highs
+51081